IP Library › Granted Patent US 8,492,396
Granted Patent B2
US 8,492,396 · App. 12/730,559 · Granted Jul 23, 2013

Therapeutic uses of adrenergic α-1 receptor antagonists

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,492,396
App. No.
12/730,559
Granted
Jul 23, 2013
Kind
B2
Abstract

The disclosure relates to methods of using an adrenergic α-1 receptor antagonist or its pharmaceutically acceptable salts for treating and/or preventing interstitial cystitis, overactive bladder or detrusor overactivity.

Claims (3)

1. A method for treating interstitial cystitis comprising administering to a patient in need thereof an effective amount of alfusozine or a pharmaceutically acceptable salt thereof, as the sole active ingredient.

2. The method according to claim 1 , wherein said pharmaceutically acceptable salt is alfuzosine hydrochloride.

3. The method according to claim 1 , wherein the patient is male.

Assignments (2)
CHANGE OF NAME Recorded Jun 20, 2012
From: SANOFI-AVENTIS
To: SANOFI
Reel/Frame 028413/0927 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2010
From: GEPPETTI, PIERANGELO
To: SANOFI-AVENTIS
Reel/Frame 025045/0214 →